NASDAQ:REGN

Regeneron Pharmaceuticals Price Target, Predictions & Analyst Ratings

$578.04
+3.43 (+0.60 %)
(As of 08/2/2021 12:04 PM ET)
Add
Compare
Today's Range
$571.18
$580.53
50-Day Range
$495.34
$589.32
52-Week Range
$441.00
$660.00
Volume6,020 shs
Average Volume880,612 shs
Market Capitalization$61.59 billion
P/E Ratio16.36
Dividend YieldN/A
Beta0.15

Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
16 Wall Street analysts have issued ratings and price targets for Regeneron Pharmaceuticals in the last 12 months. Their average twelve-month price target is $661.29, predicting that the stock has a possible upside of 14.40%. The high price target for REGN is $800.00 and the low price target for REGN is $495.00. There are currently 5 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
TypeToday30 Days Ago90 Days Ago180 Days Ago
REGN Consensus Rating: BuyBuyBuyBuy
REGN Consensus Rating Score: 2.692.752.792.75
REGN Analyst Ratings: 0 Sell Rating(s)
5 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
13 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
16 Buy Rating(s)
1 Strong Buy Rating(s)
REGN Consensus Price Target: $661.29$662.72$646.91$620.63
REGN Price Target Upside: 14.40% upside20.52% upside16.98% upside12.70% upside

Regeneron Pharmaceuticals (NASDAQ:REGN) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Regeneron Pharmaceuticals (NASDAQ:REGN) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetDetails
8/2/2021HC Wainwright
M. King
Boost Price TargetBuy$729.00 ➝ $741.00
7/23/2021Royal Bank of Canada
Kennen MacKay
Boost Price TargetSector Perform$629.00 ➝ $679.00
7/8/2021Benchmark
Boost Price TargetBuy$590.00 ➝ $636.00
5/7/2021SVB Leerink
Lower Price TargetOutperform$657.00 ➝ $641.00
5/7/2021Morgan Stanley
Boost Price TargetEqual Weight$477.00 ➝ $495.00
4/13/2021Robert W. Baird
Reiterated RatingHold
4/13/2021Canaccord Genuity
Reiterated RatingBuy
2/23/2021Credit Suisse Group
Boost Price TargetOutperform$753.00 ➝ $760.00
2/16/2021Cantor Fitzgerald
Lower Price TargetOverweight$696.00 ➝ $656.00
2/8/2021Cowen
Lower Price TargetOutperform$684.00 ➝ $565.00
1/25/2021BMO Capital Markets
UpgradeMarket Perform ➝ Outperform$630.00
1/14/2021Smith Barney Citigroup
Boost Price Target$575.00 ➝ $584.00
1/8/2021FIX
UpgradeNeutral ➝ Buy$635.00 ➝ $575.00
11/6/2020Truist
Boost Price Target$750.00 ➝ $770.00
10/1/2020JPMorgan Chase & Co.
Reiterated RatingHold
8/6/2020Barclays
Boost Price Target$615.00 ➝ $675.00
8/6/2020Oppenheimer
Hartaj Singh
Boost Price TargetOutperform$675.00 ➝ $725.00
8/6/2020Citigroup
Boost Price TargetNeutral$585.00 ➝ $635.00
8/5/2020The Goldman Sachs Group
Boost Price Target$700.00 ➝ $800.00
8/5/2020Piper Sandler
Boost Price TargetOverweight$630.00 ➝ $675.00
7/8/2020SunTrust Banks
UpgradeHold ➝ Buy$400.00 ➝ $750.00
6/12/2020Jefferies Financial Group
Biren Amin
Boost Price TargetBuy$657.00 ➝ $691.00
5/27/2020Cfra
Lower Price TargetHold$557.00 ➝ $549.00
5/26/2020Wells Fargo & Company
UpgradeEqual Weight ➝ Overweight$559.00 ➝ $734.00
3/31/2020Wolfe Research
Initiated CoverageMarket Perform$455.00
3/12/2020Argus
Jasper Hellweg
Boost Price TargetBuy$430.00 ➝ $540.00
2/26/2020Sanford C. Bernstein
UpgradeMarket Perform ➝ Outperform$500.00
2/24/2020Evercore ISI
Joshua Schimmer
UpgradeIn-Line ➝ Outperform$500.00
12/23/2019Raymond James
Dane Leone
Initiated CoverageMarket Perform
10/16/2019Bank of America
Initiated CoverageNeutral$325.00
10/8/2019Piper Jaffray Companies
Christopher Raymond
Set Price TargetBuy$435.00
9/23/2019Guggenheim
UpgradeNeutral ➝ Buy$355.00 ➝ $403.00
5/8/2019UBS Group
Lower Price TargetBuy$480.00 ➝ $440.00
(Data available from 8/2/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 8/2/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.